698 Targeting HLA-G-mediated immunosuppression with a first-in-class antagonist antibody

• Jeffrey Jones,
• Courtney Beers,
• Christina Kochel,
• Douglas Hodges,
• Michael Totagrande,
• Megan Welch,
• Bradley Spatola,
• Shelby Joe,
• John Corbin,
• Vanessa Soros,
• Achim Moesta

Affiliations

Jeffrey Jones

Tizona Therapeutics, South San Francisco, CA, USA

Courtney Beers

Aff1 grid.417886.40000000106575612Amgen Seattle WA USA

Christina Kochel

Discovery Oncology, Merck & Co. Inc, South San Francisco, California, USA

Douglas Hodges

Tizona Therapeutics, South San Francisco, CA, USA

Michael Totagrande

Tizona Therapeutics, South San Francisco, CA, USA

Megan Welch

Tizona Therapeutics, South San Francisco, CA, USA

Bradley Spatola

Tizona Therapeutics, South San Francisco, CA, USA

Shelby Joe

Tizona Therapeutics, South San Francisco, CA, USA

John Corbin

Tizona Therapeutics, South San Francisco, CA, USA

Vanessa Soros

Tizona Therapeutics, South San Francisco, CA, USA

Achim Moesta

Tizona Therapeutics, South San Francisco, CA, USA